← All medicines

Kidney medicines

Daprodustat reference

Independent educational summary · Sources checked November 20, 2026

NIH describes anemia treatment in eligible adults on dialysis. Confirm current product availability and specialist recommendations.

Profile scope: Daprodustat reference. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Abdominal discomfort or dizziness may occur.

Serious risks and warning signs

Clots, cardiovascular events, and excessively high hemoglobin are major concerns. Bleeding or severe digestive symptoms require urgent advice. The prescribed hemoglobin goal is not a target to normalize independently.

A question for your healthcare team

Is this product currently appropriate and available, and which hemoglobin checks and clot precautions are required?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.